跳至主要内容
临床试验/TCTR20200630004
TCTR20200630004招募中3 期

Regional Citrate Anticoagulation for acute intermittent hemodialysis versus saline flushing for safety, efficacy and effect on prolong life of blood circuit of hemodialysis machine; Randomized controlled trial

Government0 个研究点目标入组 300 人开始时间: 2020年6月30日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Patients were eligible for enrollment if they were aged 18 years or older
  • Patients with AKI requiring RRT, acute intermittent hemodialysis
  • Contraindication to systemic anticoagulation or medium-to high bleeding risk during hemodialysis
  • Informed consent

排除标准

  • Patients were treated with antiplatelet ,oral anticoagulant therapy or other drugs known to affect coagulation within 7 days
  • Acute liver failure or DIC
  • Abnormal plasma total calcium < 7.0 mg/dL
  • Documented arrhythmia
  • Known allergy to citrate

研究者

发起方
Government

相似试验

Regional Citrate Anticoagulation for acute... | 临床试验